Adding a Second Mutation Did Not Further Delay Cannabinoid Tolerance in Mice

Combining two biological changes does not guarantee an additional effect. A mouse study combining CB1 receptor mutations with deletion of beta-arrestin 2 found no further delay in cannabinoid tolerance beyond the receptor-mutation model alone.

Testing whether mechanisms add together

The investigators compared single- and double-mutant mice with wild-type animals. They tested THC and CP55,940 using antinociception and body-temperature outcomes. The experiment concerned genetically modified animals, not a genetic test for human cannabis impairment.

The pattern depended on drug and sex

The supplied abstract reports delayed tolerance and increased sensitivity to CP55,940 in male single- and double-mutant mice, without the same pattern for THC. Female findings depended on the drug, response and treatment history, and did not show a corresponding difference in tolerance development.

A negative incremental result is informative

If adding a second manipulation does not increase an effect, the result can constrain a proposed mechanism. It does not prove that the second protein has no function in other cells, drugs or conditions. The comparison is about additional effect within the tested models.

These findings also separate initial sensitivity from adaptation during repeated dosing. An animal can respond more strongly to an initial dose without necessarily developing tolerance at a different rate. For forensic use, neither a receptor mechanism nor a tolerance phenotype establishes an individual's preserved driving performance. The practical question remains which compound, function, treatment history and comparison produced the reported result.

Related: interpreting cannabis tolerance claims.

Research cited

Piscura MK; Sepulveda DE; Maulik M; Guindon J; Henderson-Redmond AN; Morgan DJ. Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice. The Journal of pharmacology and experimental therapeutics (2023). doi:10.1124/jpet.122.001367. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

A 2021 rat-heart experiment found evidence that endogenous cannabinoid signaling modulated angiotensin II responses. The intervention and model did not establish the cardiovascular effects of using marijuana or taking THC. The preparation isolated a mechanistic question Researchers used perfused rat hearts and confirmed cardiac CB1 receptor expression. Angiotensin infusions changed…

Spread the love

Read Article: An Isolated-Heart Study Linked Angiotensin Responses to Endocannabinoid Signaling Without Testing Marijuana

An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A 1999 isolated guinea-pig intestinal-tissue experiment found bidirectional cross-tolerance between morphine and WIN 55,212-2. Yet antagonist-triggered contraction did not appear symmetrically, limiting a simple claim that the two dependence states were identical. The model measured tissue responses Myenteric-plexus longitudinal-muscle preparations were incubated with the compounds and tested through electrically evoked…

Spread the love

Read Article: An Isolated Intestinal Cannabinoid Study Found Two-Way Cross-Tolerance but Unequal Antagonist Withdrawal Responses

A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

A 1998 mouse study used a CB1 antagonist to precipitate withdrawal after repeated THC. Its behavioral findings support an experimental dependence model, while remaining different from the natural course of human cannabis withdrawal. The trigger was an administered antagonist After repeated THC, antagonist challenge promptly increased paw tremors and head…

Spread the love

Read Article: A Mouse THC Withdrawal Model Used Receptor Blockade Rather Than Ordinary Abstinence

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us